Ondine Biomedical Inc (OBI) NPV
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Ondine Biomedical assessing Steriwave with Yorkshire partners
5 March 2024 13:50
(Sharecast News) - Ondine Biomedical announced on Tuesday that it is joining forces with the Mid Yorkshire Teaching NHS Trust, Health Innovation Yorkshire and Humber, and the York Health Economics Consortium...
-
Ondine raises $3.6m to help commercialise Steriwave
13 December 2023 14:43
(Sharecast News) - Life sciences company Ondine Biomedical has successfully raised CAD 4.91m ($3.62m), it announced on Wednesday, bolstering its efforts to commercialise its photodisinfection technology...
-
Ondine reports strong research findings from Canadian hospitals
23 October 2023 12:15
(Sharecast News) - Ondine Biomedical announced ground-breaking research findings from Vancouver General and University of British Columbia (UBC) Hospitals in British Columbia, Canada, on Monday, after they...
-
Ondine announces expanded Canadian availability of Steriwave
13 October 2023 16:15
(Sharecast News) - Life sciences company Ondine Biomedical announced the expansion of the availability of its Steriwave nasal photo disinfection technology on Friday across various hospitals in Canada.
-
Ondine disinfection tech to be used at another Canadian hospital
7 August 2023 10:57
(Sharecast News) - Ondine Biomedical announced on Monday that it is joining forces with Canada's Kelowna General Hospital (KGH) in a pilot targeting the prevention of hospital-acquired infections (HAIs).
-
Ondine Biomedical reports first-quarter progress
17 April 2023 12:06
(Sharecast News) - Life sciences company Ondine Biomedical reported a number of operational highlights in a first-quarter update on Monday, including clinical developments for US market approval, additional...
-
Ondine Biomedical upbeat on photodisinfection study
17 January 2023 17:30
(Sharecast News) - Ondine Biomedical said on Tuesday that a new study published in the journal Antibiotics found that antimicrobial photodisinfection therapy (aPDT) using its proprietary methylene blue-based...
-
Ondine reports success in MRSA clinical trial
2 December 2022 12:34
(Sharecast News) - Ondine Biomedical reported full results from its phase two 'BENEFIT-PDT' clinical trial on Friday, which met its primary endpoint of bacterial load reduction after nasal...
-
Ondine technology 'highly effective' against MRSA isolates
19 October 2022 14:00
(Sharecast News) - Canada-based life sciences company Ondine Biomedical announced new research on Wednesday, showing that its photodisinfection technology was "highly effective" against clinical...
Company announcements Announcements
-
Appointment of Interim Chief Financial Officer
28 March 2024 12:52
Ondine Biomedical Inc. NPV (CDI)
-
First commercial adoption of Steriwave by the NHS
25 March 2024 07:00
Ondine Biomedical Inc. NPV (CDI)
-
Grant of Share Options
26 January 2024 07:00
Ondine Biomedical Inc. NPV (CDI)
-
Appointment of new Chief Financial Officer
16 January 2024 08:15
Ondine Biomedical Inc. NPV (CDI)
-
TR-1: NOTIFICATION OF MAJOR HOLDINGS
12 December 2023 13:20
Ondine Biomedical Inc. NPV (CDI)
-
Result of Fundraising
11 December 2023 18:15
Ondine Biomedical Inc. NPV (CDI)
-
Result of Placing & Broker Option Update
5 December 2023 07:00
Ondine Biomedical Inc. NPV (CDI)
-
Close of Bookbuild
4 December 2023 13:28
Ondine Biomedical Inc. NPV (CDI)
-
Update. Re investor-led financing
1 December 2023 18:13
Ondine Biomedical Inc. NPV (CDI)
-
Ondine announces investor-led financing
30 November 2023 18:40
Ondine Biomedical Inc. NPV (CDI)
-
Photodisinfection recommended as Standard of Care
16 November 2023 07:00
Ondine Biomedical Inc. NPV (CDI)
-
Half-year Report
25 September 2023 09:00
Ondine Biomedical Inc. NPV (CDI)
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.